- Home
- COGT vs NFJ Comparison
COGT vs NFJ Comparison
Compare COGT & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- NFJ
- Stock Information
- Founded
- COGT 2014
- NFJ 2005
- Country
- COGT United States
- NFJ United States
- Employees
- COGT N/A
- NFJ N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- NFJ Finance: Consumer Services
- Sector
- COGT Health Care
- NFJ Finance
- Exchange
- COGT Nasdaq
- NFJ Nasdaq
- Market Cap
- COGT 1.1B
- NFJ 1.2B
- IPO Year
- COGT 2018
- NFJ N/A
- Fundamental
- Price
- COGT $12.07
- NFJ $12.85
- Analyst Decision
- COGT Strong Buy
- NFJ
- Analyst Count
- COGT 9
- NFJ 0
- Target Price
- COGT $20.25
- NFJ N/A
- AVG Volume (30 Days)
- COGT 5.0M
- NFJ 223.5K
- Earning Date
- COGT 08-05-2025
- NFJ 01-01-0001
- Dividend Yield
- COGT N/A
- NFJ 9.01%
- EPS Growth
- COGT N/A
- NFJ N/A
- EPS
- COGT N/A
- NFJ N/A
- Revenue
- COGT N/A
- NFJ N/A
- Revenue This Year
- COGT N/A
- NFJ N/A
- Revenue Next Year
- COGT N/A
- NFJ N/A
- P/E Ratio
- COGT N/A
- NFJ N/A
- Revenue Growth
- COGT N/A
- NFJ N/A
- 52 Week Low
- COGT $3.72
- NFJ $10.45
- 52 Week High
- COGT $12.97
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- COGT 78.82
- NFJ 64.33
- Support Level
- COGT $11.93
- NFJ $12.64
- Resistance Level
- COGT $12.79
- NFJ $12.83
- Average True Range (ATR)
- COGT 0.74
- NFJ 0.14
- MACD
- COGT 0.03
- NFJ 0.01
- Stochastic Oscillator
- COGT 76.56
- NFJ 92.86
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.